These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 168258)

  • 41. Inhibition of cellular immune reactions by cyclophosphamide analogues ifosfamide and trofosfamide. I. Mixed lymphocyte reaction.
    Devlin RG; Schwartz NL; Baronowsky PE; Zygmunt WA
    Proc Soc Exp Biol Med; 1974 Feb; 145(2):389-91. PubMed ID: 4273394
    [No Abstract]   [Full Text] [Related]  

  • 42. Adherent cells in tumor immunity.
    Burk MW; Burk KR; Yu S; McKhann CF
    Cell Immunol; 1977 Apr; 30(1):43-53. PubMed ID: 862034
    [No Abstract]   [Full Text] [Related]  

  • 43. Augmentation of the in vitro humoral immune response by pharmacologic agents. II: comparison of the effects of antiproliferative agents with DBcAMP.
    Burchiel SW; Melmon KL
    Immunopharmacology; 1979 Mar; 1(2):151-63. PubMed ID: 233583
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of cyclic AMP in the immunocompetent cell.
    Watts HG
    Transplantation; 1971 Sep; 12(3):229-31. PubMed ID: 4327942
    [No Abstract]   [Full Text] [Related]  

  • 45. The responsiveness of mice B-lymphocytes to neuromediators during an immune reaction.
    Ado AD; Goldshtein MM
    Brain Behav Immun; 1988 Mar; 2(1):79-85. PubMed ID: 2846098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Changes in immune reactivity of the organism and content of monoaminodicarboxylic acid and their derivatives in brain and spleen].
    Sopotsinskaia EB; Lisniak IA; Iakimenko VA
    Ukr Biokhim Zh (1978); 1980; 52(4):434-40. PubMed ID: 7210205
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhancement of natural killer cell activity in mice by treatment with a thymic factor.
    Bistoni F; Baccarini M; Puccetti P; Marconi P; Garaci E
    Cancer Immunol Immunother; 1984; 17(1):51-5. PubMed ID: 6563944
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipopolysaccharide-induced activation of suppressor cells: reversal by an agent which alters cyclic nucleotide metabolism.
    Winchurch RA; Hilberg C; Birmingham W; Munster AM
    Immunology; 1982 Jan; 45(1):147-53. PubMed ID: 6459992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New approaches to immunotherapy: thymomimetic drugs.
    Specter S; Hadden JW
    Springer Semin Immunopathol; 1985; 8(4):375-85. PubMed ID: 3879015
    [No Abstract]   [Full Text] [Related]  

  • 50. Experimental study on effects of iron deficiency anemia on immune function.
    Tian LQ; Zhu QH
    J Tongji Med Univ; 1987; 7(4):252-7. PubMed ID: 2834561
    [No Abstract]   [Full Text] [Related]  

  • 51. Studies on monoclonal anti-isotypic and anti-idiotypic antibodies against leukemia and myeloma: V. The effects of monoclonal antibodies and interferon on the levels of cyclic nucleotides in leukemic cell lines.
    Shen GX; Shao JF; Li TX; Wang XL; Zhu HF; Su N; Zhang Y; Yang DF
    J Tongji Med Univ; 1992; 12(4):197-200. PubMed ID: 1337759
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amplification of the proliferative response to alloantigen by a factor present in an extract of syngeneic thymic lymphoid cells.
    Wright PW; Loop SM
    Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4474-8. PubMed ID: 279929
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enrichment of in vitro and in vivo immunologic activity of purified fractions of calf thymic hormone.
    Yakir Y; Kook AI; Trainin N
    J Exp Med; 1978 Jul; 148(1):71-83. PubMed ID: 27568
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased reactivity of responding cells in the mixed lymphocyte reaction by a thymic humoral factor.
    Umiel T; Trainin N
    Eur J Immunol; 1975 Feb; 5(2):85-8. PubMed ID: 135681
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intracellular events involved in the induction of immune competence in lymphoid cells by a thymus humoral factor.
    Kook AI; Trainin N
    J Immunol; 1975 Jan; 114(1 Pt 1):151-7. PubMed ID: 234496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. THF, a thymic hormone, promotes interleukin-2 production in intact and thymus-deprived mice.
    Umiel T; Pecht M; Trainin N
    J Biol Response Mod; 1984 Aug; 3(4):423-34. PubMed ID: 6332883
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of immune response in allogeneic mixed spleen cell cultures. I. Influence of I-region on the generation of suppressor cells.
    Kim YT; Schwartz A; Moody C; Siskind GW; Weksler ME
    J Immunol; 1980 Oct; 125(4):1724-9. PubMed ID: 6447730
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The control exerted by thymic hormone (THF) on cellular cAMP levels and immune reactivity of spleen cells in the MLC assay.
    Kook AI; Trinin N
    J Immunol; 1975 Jul; 115(1):8-14. PubMed ID: 168258
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.